WallStreetZenWallStreetZen

NASDAQ: APGE
Apogee Therapeutics Inc Stock Ownership - Who owns Apogee Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apogee Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carl DambkowskiChief Medical Officer2026-04-01100$85.89
$8.59kSell
Carl DambkowskiChief Medical Officer2026-04-012,698$84.31
$227.47kSell
Carl DambkowskiChief Medical Officer2026-04-012,702$85.33
$230.56kSell
Jane HendersonChief Financial Officer2026-04-011,100$85.46
$94.01kSell
Jane HendersonChief Financial Officer2026-04-01900$84.46
$76.01kSell
Carl DambkowskiChief Medical Officer2026-04-014,125$22.86
$94.30kBuy
Jane HendersonChief Financial Officer2026-03-252,000$85.00
$170.00kSell
Michael Thomas HendersonChief Executive Officer2026-03-113,418$75.86
$259.29kSell
Michael Thomas HendersonChief Executive Officer2026-03-118,219$74.83
$615.03kSell
Michael Thomas HendersonChief Executive Officer2026-03-118,363$74.29
$621.29kSell

1 of 8

APGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APGE insiders and whales buy or sell their stock.

APGE Shareholders

What type of owners hold Apogee Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vr Adviser LLC12.22%8,493,321$716.33MInstitution
Fmr LLC11.84%8,225,038$693.70MInstitution
Wellington Management Group LLP6.83%4,746,585$400.33MInstitution
Blackrock Inc5.45%3,783,994$319.14MInstitution
Vanguard Group Inc4.11%2,857,824$241.03MInstitution
T Rowe Price Investment Management Inc3.93%2,732,456$230.46MInstitution
Rtw Investments LP3.90%2,712,097$228.74MInstitution
Perceptive Advisors LLC3.35%2,330,651$196.57MInstitution
Driehaus Capital Management LLC3.14%2,183,704$184.17MInstitution
Janus Henderson Group PLC2.97%2,062,604$173.96MInstitution

1 of 3

APGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APGE94.86%5.14%Net SellingNet Selling
RYTM88.64%11.36%Net SellingNet Selling
SRRK60.19%39.81%Net BuyingNet Selling
COGT92.60%7.40%Net SellingNet Selling
CGON85.41%14.59%Net BuyingNet Buying
View Top Biotech Stocks

Apogee Therapeutics Stock Ownership FAQ

Who owns Apogee Therapeutics?

Apogee Therapeutics (NASDAQ: APGE) is owned by 100.41% institutional shareholders, 5.44% Apogee Therapeutics insiders, and 0.00% retail investors. Nimish P. Shah is the largest individual Apogee Therapeutics shareholder, owning 1.75M shares representing 2.52% of the company. Nimish P. Shah's Apogee Therapeutics shares are currently valued at $147.60M.

If you're new to stock investing, here's how to buy Apogee Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.